A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder ; volume:23 ; number:4 ; day:8 ; month:11 ; year:2023 ; pages:339-362 ; date:12.2023
Drugs in R & D ; 23, Heft 4 (8.11.2023), 339-362, 12.2023
- Creator
-
Miller, James C.
Brooks, Michael A.
Wurzel, Kelly E.
Cox, Emily J.
Wurzel, John F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-023-00443-5
- URN
-
urn:nbn:de:101:1-2024021310490965476678
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Miller, James C.
- Brooks, Michael A.
- Wurzel, Kelly E.
- Cox, Emily J.
- Wurzel, John F.
- SpringerLink (Online service)
Other Objects (12)
Lower buprenorphine elimination rate constant is associated with lower opioid use
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Expanding access to medications for opioid use disorder through locally-initiated implementation
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Telehealth in opioid use disorder treatment: policy considerations for expanding access to care
Lower buprenorphine elimination rate constant is associated with lower opioid use
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Expanding access to medications for opioid use disorder through locally-initiated implementation
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Telehealth in opioid use disorder treatment: policy considerations for expanding access to care
Lower buprenorphine elimination rate constant is associated with lower opioid use
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Expanding access to medications for opioid use disorder through locally-initiated implementation
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder